Clinical Trial Update: The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients

View source ↗

Summary

A clinical trial is evaluating whether serum AKR1B10 can serve as an early biomarker to warn of hepatocellular carcinoma in patients with cirrhosis; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Snippet

Sponsor: The First Affiliated Hospital of University of South China | Conditions: Cirrhosis, Hepotacellular Carcinoma | Status: RECRUITING